What is the Society for Fetal Urology (SFU) grading system in antenatal hydronephrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is SFU in Antenatal Hydronephrosis?

The Society for Fetal Urology (SFU) grading system is a five-point classification system (grades 0-4) introduced in 1988 to standardize the assessment of hydronephrosis severity in children, based on the degree of pelvic and calyceal dilation and the thickness of renal parenchyma overlying the calices 1.

System Components

The SFU grading evaluates three key anatomical features on ultrasound 2:

  • Renal pelvis dilation - degree of pelvic expansion
  • Calyceal dilation - involvement and severity of calyceal system dilation
  • Renal parenchymal thickness - assessment of cortical preservation or thinning overlying the calices

Clinical Context and Current Use

The SFU system remains the most widely used method to grade pediatric hydronephrosis despite being over 35 years old 1. It has demonstrated good intrarater reliability (substantial to almost perfect agreement, kappa 0.56-0.89) but only modest interrater reliability, particularly for grade 3 hydronephrosis where agreement is only slight to fair 3.

Key Advantages:

  • Longer period of clinical use and validation
  • Good intrarater reliability 1
  • Widespread familiarity among clinicians 1

Important Limitations:

The SFU system has significant weaknesses that clinicians must recognize 4:

  • Operator-dependent with variable interpretation between observers
  • Grade 4 encompasses too broad a spectrum - includes both minimal medullary thinning and severe cortical thinning (cyst-like kidneys), making it inadequate for surgical decision-making
  • Does not clearly differentiate who needs surgery versus conservative management
  • Fails to account for intrarenal pelvis configuration 5

Competing Classification Systems

The Urinary Tract Dilation (UTD) classification system was introduced by a multi-organizational consensus group to improve standardization 1. The UTD system incorporates seven imaging parameters:

  1. Anterior-posterior renal pelvic diameter (APRPD)
  2. Calyceal dilation (central vs peripheral postnatally)
  3. Renal parenchymal thickness
  4. Renal parenchymal appearance
  5. Bladder abnormalities
  6. Ureteral abnormalities
  7. Amniotic fluid quantity (antenatal only)

Recent evidence suggests the UTD system may provide better interrater reliability than SFU 6, though the ACR Appropriateness Criteria (2020) continue to use SFU grading as the primary system due to its longer track record and greater familiarity 1.

Practical Application

For clinical practice, the ACR recommends using SFU grading supplemented with APRPD measurement >15 mm as a marker of severe hydronephrosis 1. This combined approach:

  • Maintains consistency with established literature
  • Adds objective measurement to subjective grading
  • Conforms to intermediate-to-high-risk UTD stratification 1

Common Pitfall to Avoid:

Do not rely on SFU grade 4 alone to make surgical decisions - this grade is too broad and may delay necessary intervention in severe cases or prompt unnecessary surgery in mild cases 4. Always correlate with APRPD measurements, renal function studies, and clinical context.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.